Page last updated: 2024-09-05

bilastine and Urticaria

bilastine has been researched along with Urticaria in 30 studies

Research

Studies (30)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's20 (66.67)24.3611
2020's10 (33.33)2.80

Authors

AuthorsStudies
Ballester Asensio, E; Rodríguez Del Río, P; Rodríguez Fernández, F; Tortajada-Girbés, M1
Abdallah, SY; Abdelhaleem, IA; Abdelshafy, AM; Ali, ST; Hassan, AF; Kamal, NM; Mohamed, HA1
Antonijoan, R; Campo, C; Coimbra, J; Gich, I; Labeaga, L; Martínez, J; Molina, P; Puntes, M1
Deng, Z; Fan, Z; Kong, D; Li, N; Liu, W; Tu, H; Wang, Q; Xue, X; Yang, X1
Church, MK; Novák, Z; Ridolo, E; Tiongco-Recto, M1
Dion, PL; Guenther, L; Hébert, J; Leek, TV; Lynde, CW; Rao, J; Sussman, G; Waserman, S1
Biswas, D; Chowdhury, SN; Das, A; Ghosh, S; Podder, I; Sengupta, S1
Browne, F; Cunningham, L; Dvorakova, V; Irvine, AD1
Barkate, H; De, A; Deshmukh, G; Dhoot, D; Kochhar, AM; Sarda, A; Shah, B1
Abad-Santos, F; Arranz, P; Belmonte, C; Elgezabal, L; Fernández, N; Hernández, G; Martín-Vilchez, S; Mejía-Abril, G; Ochoa, D; Román, M1
Biffi, A; Demonte, A; Fainello, M; Fernando, F; Guanti, MB; Liberati, S; Pepe, P1
Cordón, E; Del Mar Forés, M; Fernández, S; Labeaga, L; Riesgo, SE; Ruiz-Miján, M; Senán, MR; Sologuren, A; Viñas, R1
Altrichter, S; Church, MK; Hawro, T; Labeaga, L; Magerl, M; Maurer, M; Metz, M; Weller, K; Zuberbier, T1
Campo, C; Encinas, E; Labeaga, L; Lukas, JC; Rodriguez, M; Schmidt, S; Sologuren, A; Valiente, R; Vozmediano, V1
Bartra, J; Dávila, I; del Cuvillo, A; Ferrer, M; Jáuregui, I; Montoro, J; Mullol, J; Sastre, J; Valero, A2
Church, MK; Krause, K; Maurer, M; Spohr, A; Zuberbier, T1
Wolthers, OD1
Plichta, D; Spiewak, R1
Kiss, I; Kuna, P; Novák, Z; Tortajada-Girbés, M; Valiente, R; Yáñez, A1
Furue, M; Hide, M; Saito, A; Togawa, M; Yagami, A2
Chicharro, P; de Argila, D; Rodríguez-Jiménez, P1
Antépara, I; Bogacka, E; Jáuregui, I; Medina, I; Oanta, A; Uhl, P; Valiente, R; Wesel, F; Zuberbier, T1
Church, MK2
Antépara, I; Gamboa, PM; García-Lirio, E; Jáuregui, I; Soriano, AM1
Valero Santiago, AL1
Carter, NJ1
Scaglione, F1

Reviews

11 review(s) available for bilastine and Urticaria

ArticleYear
The Impact of Bilastine on Symptoms of Allergic Rhinitis and Chronic Urticaria: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    American journal of rhinology & allergy, 2022, Volume: 36, Issue:5

    Topics: Benzimidazoles; Chronic Urticaria; Histamine Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Piperidines; Randomized Controlled Trials as Topic; Rhinitis, Allergic; Urticaria

2022
Effect of Bilastine on Chronic Urticaria: A Systematic Review and Meta-Analysis.
    International archives of allergy and immunology, 2023, Volume: 184, Issue:2

    Topics: Chronic Urticaria; Humans; Quality of Life; Urticaria

2023
Bilastine: a lifetime companion for the treatment of allergies.
    Current medical research and opinion, 2020, Volume: 36, Issue:3

    Topics: Adolescent; Adult; Benzimidazoles; Child; Drug Interactions; Histamine H1 Antagonists; Humans; Piperidines; Pruritus; Quality of Life; Rhinitis, Allergic; Urticaria; Young Adult

2020
Multidisciplinary Real-World Experience With Bilastine, a Second Generation Antihistamine
    Journal of drugs in dermatology : JDD, 2020, Feb-01, Volume: 19, Issue:2

    Topics: Adolescent; Adult; Aged; Benzimidazoles; Child; Histamine Antagonists; Humans; Hypersensitivity; Middle Aged; Piperidines; Urticaria; Young Adult

2020
Bilastine for the treatment of urticaria.
    Expert opinion on pharmacotherapy, 2013, Volume: 14, Issue:11

    Topics: Animals; Benzimidazoles; Histamine Antagonists; Humans; Piperidines; Treatment Outcome; Urticaria

2013
[Pharmacotherapy of urticaria--an analysis of the discrepancies between guidelines of expert bodies, registration documents and evidence for the effectiveness of drugs].
    Przeglad lekarski, 2013, Volume: 70, Issue:12

    Topics: Administration, Oral; Administration, Topical; Anti-Allergic Agents; Benzimidazoles; Cetirizine; Glucocorticoids; Histamine Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Piperidines; Poland; Practice Guidelines as Topic; Terfenadine; Treatment Outcome; Urticaria

2013
Safety and efficacy of bilastine: a new H(1)-antihistamine for the treatment of allergic rhinoconjunctivitis and urticaria.
    Expert opinion on drug safety, 2011, Volume: 10, Issue:5

    Topics: Animals; Benzimidazoles; Clinical Trials, Phase I as Topic; Histamine H1 Antagonists; Humans; Piperidines; Randomized Controlled Trials as Topic; Rhinitis, Allergic, Seasonal; Urticaria

2011
An overview of the novel H1-antihistamine bilastine in allergic rhinitis and urticaria.
    Expert review of clinical immunology, 2012, Volume: 8, Issue:1

    Topics: Automobile Driving; Benzimidazoles; Cardiovascular Diseases; Clinical Trials as Topic; Histamine H1 Antagonists; Humans; Piperidines; Rhinitis, Allergic, Seasonal; Urticaria

2012
Bilastine and quality of life.
    Journal of investigational allergology & clinical immunology, 2011, Volume: 21 Suppl 3

    Topics: Benzimidazoles; Chronic Disease; Histamine H1 Antagonists; Humans; Piperidines; Quality of Life; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Urticaria

2011
Bilastine: in allergic rhinitis and urticaria.
    Drugs, 2012, Jun-18, Volume: 72, Issue:9

    Topics: Area Under Curve; Benzimidazoles; Cetirizine; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Piperidines; Randomized Controlled Trials as Topic; Rhinitis, Allergic, Perennial; Urticaria

2012
Safety profile of bilastine: 2nd generation H1-antihistamines.
    European review for medical and pharmacological sciences, 2012, Volume: 16, Issue:14

    Topics: Animals; Automobile Driving; Benzimidazoles; Conjunctivitis, Allergic; Drug Interactions; Histamine H1 Antagonists, Non-Sedating; Humans; Piperidines; Rhinitis, Allergic; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Treatment Outcome; Urticaria; Wakefulness

2012

Trials

10 trial(s) available for bilastine and Urticaria

ArticleYear
How bilastine is used to treat allergic rhinitis and urticaria in children.
    Immunotherapy, 2022, Volume: 14, Issue:1

    Topics: Adolescent; Benzimidazoles; Child; Double-Blind Method; Histamine H1 Antagonists, Non-Sedating; Humans; Piperidines; Rhinitis, Allergic; Treatment Outcome; Urticaria

2022
Lack of Clinical Relevance of Bilastine-Food Interaction in Healthy Volunteers: A Wheal and Flare Study.
    International archives of allergy and immunology, 2022, Volume: 183, Issue:12

    Topics: Area Under Curve; Cross-Over Studies; Food-Drug Interactions; Humans; Piperidines; Urticaria

2022
Effectiveness, safety, and tolerability of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic spontaneous urticaria: A double-blind, parallel group, randomized controlled trial.
    Dermatologic therapy, 2020, Volume: 33, Issue:6

    Topics: Benzimidazoles; Cetirizine; Chronic Disease; Chronic Urticaria; Double-Blind Method; Histamine H1 Antagonists, Non-Sedating; Humans; Piperidines; Quality of Life; Treatment Outcome; Urticaria

2020
Bilastine safety in drivers who need antihistamines: new evidence from high-speed simulator driving test on allergic patients.
    European review for medical and pharmacological sciences, 2018, Volume: 22, Issue:3

    Topics: Adult; Attention; Automobile Driving; Benzimidazoles; Chronic Disease; Computer Simulation; Dizziness; Female; Histamine Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Male; Middle Aged; Piperidines; Prospective Studies; Rhinitis, Allergic; Urticaria; Young Adult

2018
Up-dosing with bilastine results in improved effectiveness in cold contact urticaria.
    Allergy, 2013, Volume: 68, Issue:7

    Topics: Administration, Oral; Adult; Aged; Benzimidazoles; Chi-Square Distribution; Cold Temperature; Confidence Intervals; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Piperidines; Prospective Studies; Risk Assessment; Statistics, Nonparametric; Treatment Outcome; Urticaria; Young Adult

2013
Safety and tolerability of bilastine 10 mg administered for 12 weeks in children with allergic diseases.
    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2016, Volume: 27, Issue:5

    Topics: Adolescent; Adult; Benzimidazoles; Child; Child, Preschool; Chronic Disease; Double-Blind Method; Female; Follow-Up Studies; Histamine H1 Antagonists, Non-Sedating; Humans; Male; Piperidines; Rhinitis, Allergic, Perennial; Treatment Outcome; Urticaria

2016
Efficacy and safety of bilastine in Japanese patients with chronic spontaneous urticaria: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II/III study.
    Allergology international : official journal of the Japanese Society of Allergology, 2017, Volume: 66, Issue:2

    Topics: Adolescent; Adult; Aged; Benzimidazoles; Chronic Disease; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Male; Middle Aged; Phenotype; Piperidines; Quality of Life; Treatment Outcome; Urticaria; Young Adult

2017
One-year safety and efficacy study of bilastine treatment in Japanese patients with chronic spontaneous urticaria or pruritus associated with skin diseases.
    The Journal of dermatology, 2017, Volume: 44, Issue:4

    Topics: Adult; Benzimidazoles; Chronic Disease; Eczema; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Japan; Long Term Adverse Effects; Male; Middle Aged; Piperidines; Prurigo; Pruritus; Quality of Life; Severity of Illness Index; Treatment Outcome; Urticaria

2017
Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi-centre, double-blind, randomized, placebo-controlled study.
    Allergy, 2010, Volume: 65, Issue:4

    Topics: Adolescent; Adult; Aged; Area Under Curve; Benzimidazoles; Cetirizine; Chronic Disease; Double-Blind Method; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Male; Middle Aged; Piperidines; Quality of Life; Urticaria; Young Adult

2010
Comparative inhibition by bilastine and cetirizine of histamine-induced wheal and flare responses in humans.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2011, Volume: 60, Issue:12

    Topics: Adult; Anti-Allergic Agents; Benzimidazoles; Cetirizine; Cross-Over Studies; Double-Blind Method; Histamine; Histamine H1 Antagonists; Humans; Male; Piperidines; Skin Tests; Urticaria; Young Adult

2011

Other Studies

9 other study(ies) available for bilastine and Urticaria

ArticleYear
High-dose bilastine for the treatment of BASCULE syndrome.
    Clinical and experimental dermatology, 2021, Volume: 46, Issue:2

    Topics: Adolescent; Anemia; Benzimidazoles; Cyanosis; Exanthema; Humans; Male; Piperidines; Syndrome; Urticaria

2021
Effect of bilastine on chronic spontaneous urticaria refractory to levocetrizine: Real world experience in India.
    Dermatologic therapy, 2021, Volume: 34, Issue:1

    Topics: Benzimidazoles; Cetirizine; Chronic Disease; Chronic Urticaria; Humans; India; Piperidines; Urticaria

2021
Pharmacokinetics and Safety of a Bilastine Once-Daily, Preservative-Free, Ophthalmic Formulation.
    Advances in therapy, 2021, Volume: 38, Issue:7

    Topics: Adolescent; Adult; Benzimidazoles; Histamine H1 Antagonists, Non-Sedating; Humans; Middle Aged; Piperidines; Tandem Mass Spectrometry; Urticaria; Young Adult

2021
Open-label safety assessment of bilastine in elderly patients with allergic rhinoconjunctivitis and/or urticaria.
    Allergy and asthma proceedings, 2018, Jul-20, Volume: 39, Issue:4

    Topics: Aged; Aged, 80 and over; Benzimidazoles; Conjunctivitis, Allergic; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Histamine H1 Antagonists; Humans; Incidence; Male; Piperidines; Prospective Studies; Rhinitis, Allergic; Spain; Urticaria

2018
Updosing of bilastine is effective in moderate to severe chronic spontaneous urticaria: A real-life study.
    Allergy, 2018, Volume: 73, Issue:10

    Topics: Benzimidazoles; Chronic Disease; Humans; Piperidines; Treatment Outcome; Urticaria

2018
Model-informed pediatric development applied to bilastine: Analysis of the clinical PK data and confirmation of the dose selected for the target population.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2019, Feb-01, Volume: 128

    Topics: Area Under Curve; Benzimidazoles; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Male; Models, Biological; Piperidines; Urticaria

2019
Bilastine: a new nonsedating oral H1 antihistamine for treatment of allergic rhinoconjunctivitis and urticaria.
    BioMed research international, 2013, Volume: 2013

    Topics: Administration, Oral; Benzimidazoles; Child; Conjunctivitis, Allergic; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Male; Piperidines; Rhinitis, Allergic; Rhinitis, Allergic, Perennial; Urticaria

2013
Efficacy and Safety of Omalizumab in a Patient With Chronic Spontaneous Urticaria and Active Hepatitis B Virus Infection.
    Actas dermo-sifiliograficas, 2017, Volume: 108, Issue:4

    Topics: Anti-Allergic Agents; Benzimidazoles; Chronic Disease; Drug Therapy, Combination; Female; Hepatitis B, Chronic; Humans; Middle Aged; Omalizumab; Piperidines; Prednisone; Urticaria; Viral Load; Viremia

2017
Focusing into new challenges in allergic rhinitis and urticaria. Introduction.
    Journal of investigational allergology & clinical immunology, 2011, Volume: 21 Suppl 3

    Topics: Benzimidazoles; Histamine H1 Antagonists; Humans; Piperidines; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Urticaria

2011